DekaBank Deutsche Girozentrale’s Sarepta Therapeutics SRPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$526K Hold
30,945
﹤0.01% 975
2025
Q1
$2.16M Hold
30,945
﹤0.01% 714
2024
Q4
$3.73M Hold
30,945
0.01% 632
2024
Q3
$3.83M Hold
30,945
0.01% 637
2024
Q2
$4.88M Hold
30,945
0.01% 594
2024
Q1
$4M Hold
30,945
0.01% 622
2023
Q4
$3.01M Hold
30,945
0.01% 690
2023
Q3
$3.82M Buy
30,945
+945
+3% +$117K 0.01% 592
2023
Q2
$3.37M Sell
30,000
-9,310
-24% -$1.04M 0.01% 643
2023
Q1
$5.31M Buy
39,310
+1,350
+4% +$182K 0.01% 534
2022
Q4
$4.8M Hold
37,960
0.01% 544
2022
Q3
$4.13M Hold
37,960
0.01% 558
2022
Q2
$2.89M Hold
37,960
0.01% 645
2022
Q1
$2.98M Sell
37,960
-700
-2% -$55K 0.01% 670
2021
Q4
$3.51M Buy
38,660
+1,000
+3% +$90.8K 0.01% 649
2021
Q3
$3.33M Sell
37,660
-20,500
-35% -$1.81M 0.01% 626
2021
Q2
$4.55M Buy
58,160
+18,170
+45% +$1.42M 0.01% 544
2021
Q1
$2.91M Buy
39,990
+2,528
+7% +$184K 0.01% 607
2020
Q4
$6.42M Sell
37,462
-1,349
-3% -$231K 0.02% 399
2020
Q3
$5.51M Buy
38,811
+34,381
+776% +$4.88M 0.02% 387
2020
Q2
$717K Sell
4,430
-124
-3% -$20.1K ﹤0.01% 728
2020
Q1
$441K Sell
4,554
-1,599
-26% -$155K ﹤0.01% 783
2019
Q4
$795K Sell
6,153
-37,089
-86% -$4.79M ﹤0.01% 734
2019
Q3
$3.26M Sell
43,242
-31,938
-42% -$2.41M 0.02% 426
2019
Q2
$9.76M Buy
75,180
+45,149
+150% +$5.86M 0.05% 323
2019
Q1
$4.2M Buy
30,031
+3,826
+15% +$535K 0.03% 459
2018
Q4
$2.82M Sell
26,205
-3,826
-13% -$411K 0.02% 475
2018
Q3
$4.2M Buy
30,031
+3,231
+12% +$452K 0.02% 466
2018
Q2
$3.59M Sell
26,800
-2,600
-9% -$348K 0.02% 478
2018
Q1
$2.11M Buy
29,400
+4,667
+19% +$335K 0.01% 559
2017
Q4
$926K Hold
24,733
0.01% 704
2017
Q3
$926K Hold
24,733
0.01% 713
2017
Q2
$825K Hold
24,733
0.01% 738
2017
Q1
$718K Sell
24,733
-2,000
-7% -$58.1K 0.01% 670
2016
Q4
$758K Buy
26,733
+2,000
+8% +$56.7K 0.01% 589
2016
Q3
$1.51M Hold
24,733
0.02% 485
2016
Q2
$462K Buy
24,733
+5,250
+27% +$98.1K 0.01% 690
2016
Q1
$375K Sell
19,483
-1,600
-8% -$30.8K ﹤0.01% 715
2015
Q4
$815K Buy
21,083
+200
+1% +$7.73K 0.01% 594
2015
Q3
$671K Buy
20,883
+800
+4% +$25.7K 0.01% 619
2015
Q2
$611K Buy
20,083
+700
+4% +$21.3K 0.01% 662
2015
Q1
$257K Sell
19,383
-2,600
-12% -$34.5K ﹤0.01% 850
2014
Q4
$319K Sell
21,983
-2,000
-8% -$29K ﹤0.01% 785
2014
Q3
$506K Buy
23,983
+600
+3% +$12.7K 0.01% 651
2014
Q2
$697K Buy
23,383
+900
+4% +$26.8K 0.01% 556
2014
Q1
$540K Buy
22,483
+1,100
+5% +$26.4K 0.01% 565
2013
Q4
$444K Buy
21,383
+3,600
+20% +$74.8K 0.01% 562
2013
Q3
$840K Buy
17,783
+500
+3% +$23.6K 0.01% 462
2013
Q2
$659K Buy
+17,283
New +$659K 0.01% 427